Granite Shares Advisors LLC Dexcom Inc Transaction History

Granite Shares Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$114.22 - $140.1 $52,769 - $64,726	462 Added 7.2%	6,878 $953,000
Q4 2023 Jan 30, 2024	SELL	$75.49 - $124.16 $117,009 - $192,448	-1,550 Reduced 19.46%	6,416 $796,000
Q3 2023 Oct 31, 2023	BUY	$86.06 - $137.93 $685,553 - $1.1 Million	7,966 New	7,966 $743,000
Q2 2022 Jul 22, 2022	SELL	$67.99 - $132.89 $30,527 - $59,667	-449 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $1,223 - $1,692	-13 Reduced 2.81%	449 $229,000
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $59,999 - $75,222	462 New	462 $248,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.